In Vitro Diagnostics – Market Insights – United States
The US IVD market is expected to grow moderately through 2033, driven by the increasing prevalence of chronic and infectious diseases, the expanding aging population, and the shift toward value-based healthcare, which will fuel the uptake of novel tests and automated IVD systems that can offer improved diagnostic accuracy and reduced turnaround time.
This Medtech 360 Report provides comprehensive data and analysis on the state of the market for IVDs in the US from 2019 through 2033.
The IVD market is diverse, with multiple market segments.
Which test markets are stagnant?
Which test markets are open to innovation?
How will digital health technology be integrated into these segments?
How are the test markets expected to grow?
Which tests will experience the highest growth throughout the forecast period?
How will the adoption of newer tests affect the IVD market?
The IVD competitive landscape is dynamic.
How do strategies differ between MNCs and smaller companies in this space?
What are the key purchasing criteria laboratories consider when selecting an IVD manufacturer?
How do competitors differentiate themselves in an entrenched market?
Table of contents
- In Vitro Diagnostics - Market Insights - United States
- COVID-19 Methodology
- Abstract
- Executive Summary
- Key Report Updates
- In Vitro Diagnostics Market
- Clinical Chemistry Test Market
- Market Highlights
- Market Definitions
- Market Forecast Data
- CAGR disclaimer
- Clinical Chemistry Test Market, by Product Type, US (USD), 2019u20132033
- Clinical Chemistry Test Market, by Setting, US (USD), 2019u20132033
- Clinical Chemistry Test Market, by Test Type, US (USD), 2019u20132033
- General Chemistry Tests
- Diabetes Tests
- Therapeutic Drug Monitoring Tests
- Drug of Abuse Testing
- Specific Protein Tests
- Cardiac Marker
- Blood Gas
- Market Shares
- Competitive Insights
- Immunoassay Test Market
- Market Highlights
- Market Definitions
- Market Forecast Data
- CAGR disclaimer
- Immunoassay Test Market, by Product Type, US (USD), 2019u20132033
- Immunoassay Test Market, by Setting, US (USD), 2019u20132033
- Immunoassay Test Market, by Test Type, US (USD), 2019u20132033
- Allergy Tests
- Anemia Tests
- Bone Metabolism Tests
- Cardiac Marker Tests
- Fertility/Hormone Tests
- Infectious Disease Tests
- Specific Protein
- Thyroid Tests
- Tumor Marker Tests
- Market Shares
- Competitive Insights
- Microbiology Test Market
- Hematology and Coagulation Test Market
- Market Highlights
- Market Definitions
- Market Forecast Data
- CAGR disclaimer
- Hematology and Coagulation Test Market, by Product Type, US (USD), 2019u20132033
- Hematology and Coagulation Test Market, by Setting, US (USD), 2019u20132033
- Hematology and Coagulation Test Market, by Test Type, US (USD), 2019u20132033
- General Screening and Anticoagulation Monitoring Tests
- Prothrombin Time Tests
- D-Dimer Tests
- Fibrin Formation and Degradation Tests
- Market Shares
- Competitive Insights
- Molecular Diagnostic Test Market
- Appendix
